Chinese Journal of Pharmacovigilance ›› 2017, Vol. 14 ›› Issue (11): 697-698.
Previous Articles Next Articles
Received:
2017-12-26
Revised:
2017-12-26
Online:
2017-11-20
Published:
2017-12-26
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
[1] Plesca-Manaea L, Parvu A E, Parvu M, et al. Effects of melilotus officinalis on acute inflammation[J]. Phytother Res, 2002, 16(4):316-319. [2] Asres K, Gibbons S, Hana E, et al. Anti-inflammatory activity of extracts and a saponin isolated from Melilotus elegans[J]. Pharmazie, 2005, 60(4):310-312. [3] 徐春敏, 朱乐亭, 韩容. 草木犀流浸液片[J]. 中国新药杂志, 2007, 16(4):332-333. [4] 郭淑权. 草木犀流浸液片的药理作用及临床应用[J]. 内蒙古中医药, 2012, 31(10):104-105. [5] 吴庆华, 张福先, 陈学明, 等. 消脱止-M治疗慢性下肢静脉功能不全的多中心临床观察[J]. 心肺血管病杂志, 2010, 29(6):474-476. [6] 张强, 黄士明, 孟路阳, 等. 草木犀流浸液片治疗下肢深静脉血栓形成后遗症临床疗效研究[J]. 老年医学与保健, 2007, 13(2):115-116. [7] Wittkowsky A K. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions[J]. Semin Vasc Med, 2003, 3(3):221-230. [8] 中华医学会心血管病学分会肺血管病学组. 急性肺栓塞诊断与治疗中国专家共识(2015) [J]. 中华心血管病杂志, 2015, 44(3):197-211. [9] Heit J A. The epidemiology of venous thromboembolism in the community[J]. Arterioscler Thromb Vasc Biol, 2008, 28(3):370-372. [10] Cohen A T, Agnelli G, Anderson F A, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality[J]. Thromb Haemost, 2007, 98(4):756-764. [11] Chua Y T, Ang X L, Zhong X M, et al. Interaction between warfarin and Chinese herbal medicines[J]. Singapore Med J, 2015, 56(1):11-18. [12] Yang S H, Yu C L, Chen H Y, et al. A commonly used Chinese herbal formula, Shu-Jing-Hwo-Shiee-Tang, potentiates anticoagulant activity of warfarin in a rabbit model[J]. Molecules,2013, 18(10):11712-11723. [13] Su Q,Li Y. Interaction between warfarin and the herbal product Shengmai-yin: a case report of intracerebral hematoma[J]. Yonsei Med J, 2010, 51(5):793-796. [14] Ueng Y F,Lu C K,Yang S H, et al. Potentiation of the anticoagulation effect of warfarin by the herbal remedy Shu-Jing-Hwo-Shiee- Tang in rats: The dosing regimen and pharmacokinetic interaction[J]. Drug Metab Pharmacokinet, 2017, 32(1):85-91. [15] 张彦丽, 王景红, 顾媛媛, 等. 华法林与中草药的相互作用[J]. 中国药物警戒, 2011, 8(1):41-45. [16] Ren P,Stark P Y,Johnson R L, et al. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide[J]. J Pharmacol Exp Ther, 1977, 201(3):541-546. [17] 朱丹, 李雪丽, 黄秀兰, 等. 华法林临床应用及出血不良反应介绍[J]. 中国药物警戒, 2009, 6(12):737-740. |
[1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
[2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
[3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
[4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
[5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
[6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
[7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
[8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
[9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
[10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
[11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
[12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
[13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
[14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
[15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||